Hip Bursitis and Body Weight: What the Evidence Shows

“Hip bursitis” is the name most people hear for pain on the outside of the hip, but in most cases the bursa is not the main problem. Doctors now call it greater trochanteric pain syndrome, and the usual source is the gluteal tendons that attach to the bony point of the hip ^[1]. It is far more common in women ^[2]. People with it tend to weigh more than people without it ^[4], yet the link to body weight is weaker than many assume, and no trial has tested weight loss as a treatment. The best-tested treatment is a specific education and exercise program, which beat a steroid injection on overall improvement at both eight weeks and one year in a randomized trial ^[8].

The honest summary

• Most “bursitis” is really a tendon problem. In 877 people scanned for outer hip pain, 79.8% had no bursitis on ultrasound, while 49.9% had gluteal tendinosis ^[1].
• Women are affected far more often. In a community study of 3,026 adults aged 50 to 79, women had 3.37 times the odds of the condition ^[2]. A 60,610-person database study put women’s risk at 3.3 times that of men ^[3].
• The weight link is real but loose. People with the condition have a higher BMI than healthy controls, though the evidence quality is very low ^[4]. In the community study, BMI was no longer linked once knee arthritis and back pain were accounted for ^[2].
• Higher BMI goes with more severe symptoms. Among 204 people with confirmed gluteal tendinopathy, the most severe group had a higher BMI and larger waist than the mildest group ^[6].
• No trial has tested weight loss as a treatment, and no GLP-1 study exists. Any benefit from losing weight is a reasonable hope, not a proven effect.
• Education plus exercise beat a steroid shot. In the LEAP trial, 77.3% of the exercise group reported success at eight weeks, versus 58.5% after an injection and 29.4% with wait and see ^[8].

Hip bursitis is usually gluteal tendinopathy

The bony bump you can feel on the outside of your upper thigh is the greater trochanter. Two hip muscles, the gluteus medius and gluteus minimus, attach to it by tendons, and several small fluid-filled sacs called bursae sit over it. For a long time, pain in this spot was blamed on an inflamed bursa, which is where the name trochanteric bursitis comes from.

Imaging changed that picture. Radiologists at Thomas Jefferson University reviewed six years of ultrasound scans in 877 people referred for this pain ^[1]. Only 177 (20.2%) had bursitis. Almost half (49.9%) had gluteal tendinosis, and 28.5% had a thickened iliotibial band, the tough strip of tissue that runs down the outer thigh. The authors concluded that the pain usually comes from some mix of the gluteal tendons and the iliotibial band, with bursitis present in a minority.

That is why many clinicians now prefer the broader term greater trochanteric pain syndrome, or GTPS, and why the newer trials enroll people with gluteal tendinopathy. A scan is not the whole story, though. In a small study of women, all 16 who had symptoms showed gluteal tendon changes on MRI, but so did 88% of women with no pain at all ^[7]. A tendon change on a scan does not by itself explain your pain.

Symptoms, and why women get it more

The condition shows up as pain and tenderness over the greater trochanter that often interferes with sleep and physical function ^[8]. Pressing on the bony point usually hurts. In a study comparing ten clinical tests in women, the most accurate were palpation of the greater trochanter, the FABER test (short for flexion, abduction and external rotation of the hip), resisted hip abduction (pushing the leg out to the side against resistance) and the resisted external derotation test ^[7].

For women searching their own symptoms, the sex difference is striking. In the Multicenter Osteoarthritis Study of 3,026 adults aged 50 to 79, the condition affected one hip in 15.0% of women and both hips in 8.5% ^[2]. For men, the figures were 6.6% and 1.9%. After accounting for other factors, women had 3.37 times the odds (95% CI 2.67 to 4.25). A 2023 Israeli database study of 60,610 people found the same pattern, with women 3.3 times as likely to be diagnosed ^[3].

Why women are affected more is not settled. A study of women in Canberra found that those who needed surgery for torn gluteal tendons more often had a lower angle between the femoral neck and shaft, a feature of hip shape ^[5]. Menopause is another candidate, because the condition is most common in postmenopausal women ^[10]. A trial in 132 postmenopausal women tested menopausal hormone therapy and found that hormone cream added benefit only in women with a BMI under 25 ^[10]. That result is covered further in the weight section below.

Does body weight raise the risk?

People with this condition do tend to be heavier. A 2019 systematic review pooled 13 studies comparing 229 people with the condition against 193 healthy controls and found the group with pain had a greater BMI and a wider trochanter region ^[4]. The reviewers rated the overall quality of evidence as very low, meaning the true difference could be quite different from what these small studies show. The Canberra study likewise found that greater adiposity was associated with the condition in women ^[5].

The largest population study points the other way. In the Multicenter Osteoarthritis Study, once the analysis accounted for knee arthritis, low back pain and iliotibial band tenderness, a BMI of 30 or more was no longer associated with the condition compared with a BMI under 25 (OR 1.10, 95% CI 0.80 to 1.52) ^[2]. Knee arthritis on the same side (OR 3.47) and low back pain (OR 2.79) were far stronger signals. One reading is that weight acts partly through those other conditions rather than directly on the hip tendons.

Weight seems to matter more for how bad the pain gets than for whether it starts. In 204 people with MRI-confirmed gluteal tendinopathy, the group with the most severe pain and disability had a higher BMI and larger waist than the mildest group, along with higher depression scores and more catastrophizing about pain ^[6]. Hip strength did not differ between severity groups. Diabetes may also play a role. In the Israeli database study, people with diabetes had 56% higher odds of a trochanteric bursitis diagnosis (OR 1.558) ^[3].

Does losing weight help hip bursitis?

No randomized trial or cohort study has tested weight loss as a treatment for greater trochanteric pain syndrome or gluteal tendinopathy. That means there is no direct answer. What exists is indirect.

The severity data suggest that heavier people with the condition tend to have worse symptoms ^[6], which makes weight a plausible target. The hormone therapy trial adds a second clue ^[10]. All four groups in that trial improved, and everyone in it received education about avoiding tendon compression and managing load. But the hormone cream only gave extra benefit in women with a BMI under 25, and the effect was large enough to matter (a 16.71-point better score on the main gluteal tendinopathy questionnaire at 52 weeks). Women with higher BMI did not get that boost. That finding came from a subgroup analysis in one trial, so it should not be over-read.

Taken together, losing weight is a reasonable part of a plan, especially if knee arthritis or back pain is also in the picture, since both were strongly tied to this condition ^[2]. It should not replace the treatment that has been tested. If weight and joint pain are a wider concern for you, the same pattern of strong association but thin treatment evidence appears in low back pain and sciatica and in plantar heel pain.

Treatment: education plus exercise versus a steroid shot

The LEAP trial is the key study here. Researchers in Brisbane and Melbourne randomized 204 people aged 35 to 70 with at least three months of outer hip pain and MRI-confirmed gluteal tendinopathy; 167 were women and the average age was 54.8 ^[8]. One group had 14 physiotherapy sessions over eight weeks combining education and targeted exercise. One group had a single ultrasound-guided corticosteroid injection. The third group had a single session of advice and was then left to wait and see.

The education part focused on avoiding positions and movements that press the gluteal tendons against the bone, and on building up tendon load gradually. The exercise part targeted the gluteus medius and minimus with progressive strengthening ^[8].

At eight weeks, both active treatments beat wait and see, and education plus exercise beat the injection. Average pain was 1.5 out of 10 in the exercise group, 2.7 after the injection and 3.8 with wait and see ^[8]. At one year, education plus exercise still led on overall improvement. Pain scores at one year were similar for the exercise and injection groups (2.1 and 2.3), and both were lower than wait and see (3.2).

An earlier Dutch trial in primary care tells a similar story about injections ^[9]. Among 120 patients, 55% of those given a corticosteroid injection had recovered at three months, compared with 34% on usual care. By 12 months the gap had closed: 61% versus 60%. The injection speeds up early relief, but it does not seem to change where people end up a year later.

Is there any GLP-1 data?

No. As of October 2026, no published study has looked at semaglutide, tirzepatide or any other GLP-1 medication in people with greater trochanteric pain syndrome, gluteal tendinopathy or trochanteric bursitis. Any effect would have to come through weight loss, and as covered above, even ordinary weight loss has not been tested for this condition. For what is known about GLP-1 drugs and joint pain from arthritis, see the STEP 9 knee osteoarthritis trial.

One practical point applies. People who lose weight often start walking more at the same time. Tendons respond to load, and the LEAP program built load up gradually rather than all at once ^[8]. If your outer hip starts to ache as you ramp up activity, that is a reason to pace the increase, not to stop moving.

Practical guidance

• Get a proper examination. Simple clinic tests, such as pressing on the bony point and resisted hip movements, were the most accurate way to diagnose it in one study ^[7].
• Do not read too much into a scan. In one small study, 88% of women with no hip pain had gluteal tendon changes on MRI ^[7].
• Start with education and targeted exercise. It had the best results at both eight weeks and one year in the LEAP trial ^[8].
• Treat an injection as short-term relief. Its benefit over usual care was clear at three months and gone by 12 months ^[9].
• Weight loss is a reasonable add-on, not a substitute. Higher BMI tracks with more severe symptoms ^[6], but no trial has tested weight loss as a treatment.
• Mention knee or back pain. Both are strongly linked to this condition and may change your plan ^[2].